Get started
Author

Ana Kalaba

Observed name: A Kalaba
ORCID: 0009-0001-4416-5427
Observed ORCID: 0009-0001-4416-5427
OpenAlex ID: A5002023907
P704 The effect of antiTNFα and anti-integrin agents on liver steatosis in inlamatory bowel disease patients with non-alcoholic fatty liver disease
2023 · M Mitrovic, S Marković, et al. · Journal of Crohn s and Colitis · 3
PDF
Infliximab Rescue in Acute Severe Ulcerative Colitis Complicated by Clostridium Difficile Infection: A Case Series
2021 · Srdjan Markovic, Marijana Jankovic, et al. · Cureus · 3
PDF
Drug interactions in hospitalized patients: Critical importance of renal disease and drug monitoring based on data from hospital departments of internal medicine in Serbia
2025 · Aneta Drndarević, Ivana Draganov, et al. · International Journal of Clinical Pharmacology and Therapeutics · 2
P0996 Advanced Therapies Reshape Liver Steatosis Outcomes in Inflammatory Bowel Disease: A Prospective Cohort Analysis
2026 · M Mitrovic, T Knezevic, et al. · Journal of Crohn s and Colitis · 1
P330 Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccination
2022 · T Knezevic, D Cujic, et al. · Journal of Crohn s and Colitis · 1
The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy
2021 · Srdjan Markovic, Tamara Knezevic Ivanovski, et al. · Inflammatory Bowel Diseases · 1
PDF
P1187 Human Papillomavirus Epidemiology in Anti-TNFα–Treated Women: Contrasting Patterns Between Inflammatory Bowel Disease Patients and Rheumatoid Arthritis
2026 · M Mitrovic, T Knezevic, et al. · Journal of Crohn s and Colitis
P1020 Association of Post-Induction Ustekinumab levels with treatment response in inflammatory bowel disease patients
2026 · D Kralj, N Paravina, et al. · Journal of Crohn s and Colitis
PDF
P0209 Building Serbia’s First IBD Data Warehouse: Early Results from Serbia’s BIOTHER IBD Platform
2026 · T Knezevic, R Matic, et al. · Journal of Crohn s and Colitis
PDF
P1124 Disease Clearence after Acute Severe Ulcerative Colitis episode: is it possible ?
2025 · S Markovic, Đ Kralj, et al. · Journal of Crohn s and Colitis
P0623 Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study
2025 · S Markovic, D Kralj, et al. · Journal of Crohn s and Colitis
Drug-Related Problems Prior to Hospitalization on Internal Medicine Wards
2024 · Ivana Draganov, Aneta Drndarević, et al. · Acta Poloniae Pharmaceutica - Drug Research
PDF
P792 Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients
2023 · S Markovic, D Kralj, et al. · Journal of Crohn s and Colitis
PDF
Short Term Outcome of Saccharomyces boulardii impact the Quality of Life in Patients with Inflammatory Bowel Diseases: A Multicenter, Double Blind, Placebo-Controlled Trial
2021 · Srdjan Markovic, Nikola Panic, et al. · Acta Scientific Gastrointestinal Disorders
P497 Is mucosal healing sufficient paramater for anti-TNF discontinuation?
2020 · T Knezevic, M Milic, et al. · Journal of Crohn s and Colitis
PDF
P370 Quality of life of patients with inflammatory bowel diseases in remission on different forms of treatment
2019 · A Kalaba, M Markovic, et al. · Journal of Crohn s and Colitis
Pseudomembranous colitis with longstanding ulcerative colitis
2011 · Ana Kalaba, Jelena Petković, et al.
Works count: 17
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type